Radiation Oncology/Therapy: Page 11

United Imaging goes public on Shanghai stock exchange

By AuntMinnieEurope.com staff writers

United Imaging Healthcare on 22 August launched an initial public offering on the Science and Technology Innovation Board of the Shanghai Stock Exchange.

August 22, 2022

U.K. issues statement on radiation-induced skin reactions

By AuntMinnieEurope.com staff writers

The U.K. Society of Radiographers (SoR) has highlighted a position statement about how radiation-induced skin reactions can present across different skin tones.

August 11, 2022

NELSON lung screening protocol beats NLST for cancer detection

By Frances Rylands-Monk

In a face-off between CT lung cancer screening trials, the protocol used to analyze lung nodules in the Dutch-Belgian Randomized Lung Cancer Screening (NELSON) trial proved more sensitive than that used in the U.S. National Lung Screening Trial (NLST).

August 8, 2022

Analysis shows Europe-wide CT lung screening would save lives

By Frances Rylands-Monk

Rolling out a population-based CT lung cancer screening program across Europe would prevent 18,000 premature lung cancer deaths at a cost of 937 million euros, according to a budget impact analysis presented at the International Association for the Study of Lung Cancer 2022 World Conference on Lung Cancer on 7 August.

August 7, 2022

Radiopharm collaborates with Lantheus on theranostic agent

By AuntMinnieEurope.com staff writers

Radiopharm Theranostics has entered a collaboration agreement with Lantheus to develop NM-01, a nanobody that can be labeled with radioisotopes to diagnose and treat tumors for theranostic applications.

August 4, 2022

RANZCR: Workforce challenges face radiation oncology in New Zealand

By Brian Casey

A shortage of radiation oncologists may be looming in New Zealand, according to the results of a survey that are being presented at this week's New Zealand Annual Scientific Meeting 2022, hosted by the Royal Australian and New Zealand College of Radiologists (RANZCR).

August 4, 2022

Oncology journal seeks editor in chief

By AuntMinnieEurope.com staff writers

International monthly scientific journal Clinical Oncology is seeking an editor in chief to oversee publication and lead the editorial office.

July 28, 2022

French university hospital picks ViewRay rad therapy system

By AuntMinnieEurope.com staff writers

ViewRay said Centre Oscar Lambret has become the first university hospital in Lille, France, to acquire its MRIdian MRI-guided radiation therapy system.

July 28, 2022

ITM selects Marx as chief business officer

By AuntMinnieEurope.com staff writers

German radiopharmaceutical developer ITM Isotope Technologies Munich has named Sebastian Marx, PhD, as its chief business officer.

July 21, 2022

NorthStar inks Ac-225 supply deal with Clovis

By AuntMinnieEurope.com staff writers

NorthStar Medical Radioisotopes has signed a long-term supply agreement with Clovis Oncology for NorthStar's actinium-225 (Ac-225) therapeutic radioisotope.

July 21, 2022

Clarity completes recruitment for prostate cancer trial

By AuntMinnieEurope.com staff writers

Australian radiopharmaceutical developer Clarity Pharmaceuticals has completed recruitment for a PET study of its theranostic agent with copper-based radioisotopes for treating patients with prostate cancer.

July 19, 2022

ECR: Should patient shielding stay or should it go?

By Will Morton

European experts are gradually reaching a consensus that radiation shielding is no longer needed for some imaging exams, yet this notion is proving a hard pill to swallow at some hospitals. With that in mind, a panel discussion held on Friday at ECR 2022 addressed the pros and cons of the issue.

July 15, 2022

Previous Page

Page 11 of 129

Next Page